Virax Biolabs Group Limit... (VRAX)
NASDAQ: VRAX
· Real-Time Price · USD
0.62
-0.02 (-3.16%)
At close: Oct 16, 2025, 3:59 PM
0.63
1.17%
After-hours: Oct 16, 2025, 07:55 PM EDT
-3.16% (1D)
| Bid | 0.59 |
| Market Cap | 2.7M |
| Revenue (ttm) | 6.33K |
| Net Income (ttm) | -6.06M |
| EPS (ttm) | -1.62 |
| PE Ratio (ttm) | -0.38 |
| Forward PE | -0.66 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 0.62 |
| Volume | 888,402 |
| Avg. Volume (20D) | 605,085 |
| Open | 0.62 |
| Previous Close | 0.64 |
| Day's Range | 0.60 - 0.70 |
| 52-Week Range | 0.52 - 3.62 |
| Beta | 1.62 |
| Ex-Dividend Date | n/a |
About VRAX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VRAX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VRAX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts